Advanced search
Publication Cover
Human Vaccines & Immunotherapeutics Volume 18, 2022 - Issue 2: Passive Immunization
Submit an article Journal homepage
3,112
Views
9
CrossRef citations to date
0
Altmetric
Passive SF – Review

Polyclonal hyper immunoglobulin: A proven treatment and prophylaxis platform for passive immunization to address existing and emerging diseases

Tharmala Tharmalingama Therapeutics Business Unit, Emergent BioSolutions Incorporated, Winnipeg, MB, CanadaView further author information
,
Xiaobing Hana Therapeutics Business Unit, Emergent BioSolutions Incorporated, Winnipeg, MB, Canada;b Department of Immunology, Max Rady College of Medicine, University of Manitoba, Winnipeg, MB, CanadaView further author information
,
Ashley Wozniaka Therapeutics Business Unit, Emergent BioSolutions Incorporated, Winnipeg, MB, CanadaView further author information
&
Laura Sawarda Therapeutics Business Unit, Emergent BioSolutions Incorporated, Winnipeg, MB, Canada;c Department of Medical Microbiology and Infectious Diseases, Max Rady College of Medicine, University of Manitoba, Winnipeg, MB, CanadaCorrespondence[email protected]
View further author information
Article: 1886560 | Received 18 Dec 2020, Accepted 01 Feb 2021, Published online: 19 May 2021

Reprints and Permissions

Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.

To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.

Order Reprints Request Permissions

For more information please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.